Accesso libero

Effect of hypoxia on the expression of genes encoding insulin-like growth factors and some related proteins in U87 glioma cells without IRE1 function

INFORMAZIONI SU QUESTO ARTICOLO

Cita

Abu Shehab M, Damerill I, Shen T, Rosario FJ, Nijland M, Nathanielsz PW, Kamat A, Jansson T, Gupta MB. Liver mTOR controls IGF-I bioavailability by regulation of protein kinase CK2 and IGFBP-1 phosphorylation in fetal growth restriction. Endocrinology 155, 1327-1339, 2014.10.1210/en.2013-1759395959924437487Search in Google Scholar

Acosta-Alvear D, Zhou Y, Blais A, Tsikitis M, Lents NH, Arias C, Lennon CJ, Kluger Y, Dynlacht DD. XBP1 controls diverse cell type- and condition-specifi c transcriptional regulatory networks. Molecular Cell 27, 53-66, 2007.10.1016/j.molcel.2007.06.01117612490Search in Google Scholar

Aragon T, van Anken E, Pincus D, Serafimova IM, Korennykh AV, Rubio CA, Walter P. Messenger RNA targeting to endoplasmic reticulum stress signalling sites. Nature 457, 736-740, 2009.10.1038/nature07641276853819079237Search in Google Scholar

Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proc Natl Acad Sci U S A 107, 15553-15558, 2010.10.1073/pnas.0914072107293260020702765Search in Google Scholar

Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.10.1186/1471-2407-13-597387867024330607Search in Google Scholar

Azar WJ, Azar SH, Higgins S, Hu JF, Hoff man AR, Newgreen DF, Werther GA, Russo VC. IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. Endocrinology 152, 3332-3342, 2011.10.1210/en.2011-112121750048Search in Google Scholar

Baxter RC. IGF binding proteins in cancer: mechanistic and clinical insights. Nat Rev Cancer 14, 329-341, 2014.10.1038/nrc372024722429Search in Google Scholar

Bochkov VN, Philippova M, Oskolkova O, Kadl A, Furnkranz A, Karabeg E, Breuss J, Minchenko OH, Mechtcheriakova D, Hohensinner P, Rychli K, Wojta J, Resink T, Binder BR, Leitinger N. Oxidized phospholipids stimulate angiogenesis via induction of VEGF, IL-8, COX-2 and ADAMTS-1 metalloprotease, implicating a novel role for lipid oxidation in progression and destabilization of atherosclerotic lesions. Circ Res 99, 900-908, 2006.10.1161/01.RES.0000245485.04489.ee16973904Search in Google Scholar

Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E, Quest AF, Lavandero S. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 301, 215-290, 2013.10.1016/B978-0-12-407704-1.00005-1366655723317820Search in Google Scholar

Cao SS, Kaufman RJ. Targeting endoplasmic reticulum stress in metabolic disease. Expert Opin Th er Targets 17, 437-448, 2013.10.1517/14728222.2013.75647123324104Search in Google Scholar

Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov 5, 586-597, 2015.10.1158/2159-8290.CD-14-149025977222Search in Google Scholar

Clarke HJ, Chambers JE, Liniker E, Marciniak SJ. Endoplasmic reticulum stress in malignancy. Cancer Cell 25, 563-573, 2014.10.1016/j.ccr.2014.03.01524823636Search in Google Scholar

Contois LW, Akalu A, Caron JM, Tweedie E, Cretu A, Henderson T, Liaw L, Friesel R, Vary C, Brooks PC. Inhibition of tumor-associated αvβ3 integrin regulates the angiogenic switch by enhancing expression of IGFBP-4 leading to reduced melanoma growth and angiogenesis in vivo. Angiogenesis 18, 31-46, 2015.10.1007/s10456-014-9445-2428151225249331Search in Google Scholar

Custodio RJ, do Carmo Custodio VI, Scrideli CA, Sader Milani SL, Cervi MC, Cupo P, Martinelli CE Jr. Impact of hypoxia on IGF-I, IGF-II, IGFBP-3, ALS and IGFBP-1 regulation and on IGF1R gene expression in children. Growth Horm IGF Res 22, 186-191, 2012.10.1016/j.ghir.2012.07.00122901623Search in Google Scholar

Dai G, Peng T, Zhou X, Zhu J, Kong Z, Ma L, Xiong Z, Yuan Y. Clinical significance of proliferation, apoptosis and senescence of nasopharyngeal cells by the simultaneously blocking EGF, IGF-1 receptors and Bcl-xl genes. Biochem Biophys Res Commun 440, 479-484, 2013.10.1016/j.bbrc.2013.08.07024055032Search in Google Scholar

Dejeans N, Pluquet O, Lhomond S, Grise F, Bouchecareilh M, Juin A, Meynard-Cadars M, Bidaud-Meynard A, Gentil C, Moreau V, Saltel F, Chevet E. Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA. J Cell Sci 125, 4278-4287, 2012.Search in Google Scholar

Drogat B, Auguste P, Nguyen DT, Bouchecareilh M, Pineau R, Nalbantoglu J, Kaufman RJ, Chevet E, Bikfalvi A, Moenner M. IRE1 signaling is essential for ischemia-induced vascular endothelial growth factor-A expression and contributes to angiogenesis and tumor growth in vivo. Cancer Res 67, 6700-6707, 2007.10.1158/0008-5472.CAN-06-323517638880Search in Google Scholar

Duan C, Ren H, Gao S. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation. Gen Comp Endocrinol 167, 344-351, 2010.10.1016/j.ygcen.2010.04.00920403355Search in Google Scholar

Ellis BC, Graham LD, Molloy PL. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism. Biochim Biophys Acta 1843, 372-386, 2014.10.1016/j.bbamcr.2013.10.01624184209Search in Google Scholar

Gealekman O, Gurav K, Chouinard M, Straubhaar J, Thompson M, Malkani S, Hartigan C, Corvera S. Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4. J Biol Chem 289, 18327-18338, 2014.10.1074/jbc.M113.545798414025524778188Search in Google Scholar

Girnita L, Worrall C, Takahashi S, Seregard S, Girnita A. Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation. Cell Mol Life Sci 71, 2403-2427, 2014.10.1007/s00018-013-1514-y405583824276851Search in Google Scholar

Halje M, Nordin M, Bergman D, Engstrom W. Review. The effect of insulin-like growth factor II in the regulation of tumour cell growth in vitro and tumourigenesis in vivo. In Vivo 26, 519-526, 2012.Search in Google Scholar

Han J, Back SH, Hur J, Lin YH, Gildersleeve R, Shan J, Yuan CL, Krokowski D, Wang S, Hatzoglou M, Kilberg MS, Sartor MA, Kaufman RJ. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol 15, 481-490, 2013.10.1038/ncb2738369227023624402Search in Google Scholar

Han J, Kaufman RJ. Measurement of the unfolded protein response to investigate its role in adipogenesis and obesity. Methods Enzymol 538, 135-150, 2014.10.1016/B978-0-12-800280-3.00008-624529437Search in Google Scholar

Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-alpha activation in breast cancer cells in an IGF-independent manner. Cell Signal 25, 1395-1402, 2013.10.1016/j.cellsig.2013.02.01823499909Search in Google Scholar

Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem 285, 30233-30246, 2010.10.1074/jbc.M110.122226294327820353938Search in Google Scholar

Jepsen MR, Kloverpris S, Mikkelsen JH, Pedersen JH, Fuchtbauer EM, Laursen LS, Oxvig C. Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J Biol Chem 290, 3430-3439, 2015. 10.1074/jbc.M114.611665431901225533459Search in Google Scholar

Langlais P, Yi Z, Finlayson J, Luo M, Mapes R, De Filippis E, Meyer C, Plummer E, Tongchinsub P, Mattern M, Mandarino LJ. Global IRS-1 phosphorylation analysis in insulin resistance. Diabetologia 54, 2878-2889, 2011.10.1007/s00125-011-2271-9388216521850561Search in Google Scholar

Lee J, Ozcan U. Unfolded protein response signaling and metabolic diseases. J Biol Chem 289, 1203-1211, 2014.10.1074/jbc.R113.534743389430624324257Search in Google Scholar

Lenihan CR, Taylor CT. Th e impact of hypoxia on cell death pathways. Biochem Soc Trans 41, 657-663, 2013.10.1042/BST2012034523514172Search in Google Scholar

Limesand KH, Chibly AM, Fribley A. Impact of targeting insulin-like growth factor signaling in head and neck cancers. Growth Horm IGF Res 23, 135-140, 2013.10.1016/j.ghir.2013.06.001375504223816396Search in Google Scholar

Manie SN, Lebeau J, Chevet E. Cellular mechanisms of endoplasmic reticulum stress signaling in health and disease. 3. Orchestrating the unfolded protein response in oncogenesis: an update. Am J Physiol Cell Physiol 307, C901-C907, 2014.10.1152/ajpcell.00292.201425186011Search in Google Scholar

Maurel M, Samali A, Chevet E. Endoplasmic reticulum stress: at the crossroads of inflammation and metabolism in hepatocellular carcinoma development. Cancer Cell 26, 301-303, 2014a.10.1016/j.ccr.2014.08.00725203316Search in Google Scholar

Maurel M, Chevet E, Tavernier J, Gerlo S. Getting RIDD of RNA: IRE1 in cell fate regulation. Trends Biochem Sci 39, 245-254, 2014b.10.1016/j.tibs.2014.02.00824657016Search in Google Scholar

Minchenko DO, Karbovskyi LL, Danilovskyi SV, Moenner M, Minchenko OH. Eff ect of hypoxia and glutamine or glucose deprivation on the expression of retinoblastoma and retinoblastoma-related genes in ERN1 knockdown glioma U87 cell line. Am J Mol Biol 2, 142-152, 2012.10.4236/ajmb.2012.21003Search in Google Scholar

Minchenko OH, Kharkova AP, Bakalets TV, Kryvdiuk IV. Endoplasmic reticulum stress, its sensor and signaling systems and the role in regulation of gene expressions at malignant tumor growth and hypoxia. Ukr Biokhim Zh 85, 5-16, 2013a.10.15407/ubj85.05.00524479318Search in Google Scholar

Minchenko DO, Kharkova AP, Hubenia OV, Minchenko OH. Insulin receptor, IRS1, IRS2, INSIG1, INSIG2, RRA D, and BAIAP2 gene expressions in glioma U87 cells with ERN1 loss of function: effect of hypoxia and glutamine or glucose deprivation. Endocr Regul 47, 15-26, 2013b.10.4149/endo_2013_01_1523363253Search in Google Scholar

Minchenko DO, Danilovskyi SV, Kryvdiuk IV, Bakalets TV, Lypova NM, Karbovskyi LL, Minchenko OH. Inhibition of ERN1 modifies the hypoxic regulation of the expression of TP53-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 1, 18-26, 2014.10.2478/ersc-2014-0001Search in Google Scholar

Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. Expression of insulin-like growth factor binding protein genes and its hypoxic regulation in U87 glioma cells depends on ERN1 mediated signaling pathway of endoplasmic reticulum stress. Endocr Regul 49, 73-83, 2015a.10.4149/endo_2015_02_7325960008Search in Google Scholar

Minchenko DO, Kharkova AP, Tsymbal DO, Karbovskyi LL, Minchenko OH. Inhibition of IRE1 affects the expression of insulin-like growth factor binding protein genes and modifies its sensitivity to glucose deprivation on in U87 glioma cells. Endocr Regul 49, 185-197, 2015b.10.4149/endo_2015_04_18526494037Search in Google Scholar

Minchenko OH, Tsymbal DO, Moenner M, Minchenko DO, Kovalevska OV, Lypova NM. Inhibition of the endoribonuclease of ERN1 signaling enzyme affects the expression of proliferation-related genes in U87 glioma cells. Endoplasm Reticul Stress Dis 2, 18-29, 2015c.10.1515/ersc-2015-0002Search in Google Scholar

Okon IS, Coughlan KA, Zou MH. Liver kinase B1 expression promotes phosphatase activity and abrogation of receptor tyrosine kinase phosphorylation in human cancer cells. J Biol Chem 289, 1639-1648, 2014.10.1074/jbc.M113.500934389434324285539Search in Google Scholar

Ohlsson C, Mohan S, Sjogren K, Tivesten A, Isgaard J, Isaksson O, Jansson JO, Svensson J. Th e role of liver-derived insulin-like growth factor-I. Endocr Rev 30, 494-535, 2009.10.1210/er.2009-0010275970819589948Search in Google Scholar

Pan Y, Liang H, Liu H, Li D, Chen X, Li L, Zhang CY, Zen K. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol 192, 437-446, 2014.10.4049/jimmunol.130179024307738Search in Google Scholar

Panda AC, Grammatikakis I, Yoon JH, Abdelmohsen K. Posttranscriptional regulation of insulin family ligands and receptors. Int J Mol Sci 14, 19202-19229, 2013.10.3390/ijms140919202379482924051403Search in Google Scholar

Philippou A, Maridaki M, Pneumaticos S, Koutsilieris M. The complexity of the IGF1 gene splicing, posttranslational modifi cation and bioactivity. Mol Med 20, 202-214, 2014.10.2119/molmed.2014.00011402278424637928Search in Google Scholar

Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M, Combe C, Loriot S, Cubel G, Dugot-Senant N, Vital A, Loiseau H, Gosline SJ, Taouji S, Hallett M, Sarkaria JN, Anderson K, Wu W, Rodriguez FJ, Rosenbaum J, Saltel F, Fernandez-Zapico ME, Chevet E. Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα. Cancer Res 73, 4732-4743, 2013.10.1158/0008-5472.CAN-12-3989391571623752693Search in Google Scholar

Pluquet O, Dejeans N, Chevet E. Watching the clock: endoplasmic reticulum-mediated control of circadian rhythms in cancer. Ann Med 46, 233-243, 2014.10.3109/07853890.2013.87466424491143Search in Google Scholar

Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 8, 915-928, 2008.10.1038/nrc253619029956Search in Google Scholar

Praveen Kumar VR, Sehgal P, Th ota B, Patil S, Santosh V, Kondaiah P. Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion. J Neurooncol 116, 455-464, 2014. 10.1007/s11060-013-1324-y24395346Search in Google Scholar

Singh P, Alex JM, Bast F. Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer. Med Oncol 31, 805, 2014.10.1007/s12032-013-0805-324338270Search in Google Scholar

Tomblin JK, Salisbury TB. Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells. Biochem Biophys Res Commun 443, 1092-1096, 2014.10.1016/j.bbrc.2013.12.112393262124380854Search in Google Scholar

Wang S, Kaufman RJ. The impact of the unfolded protein response on human disease. J Cell Biol 197, 857-867, 2012.10.1083/jcb.201110131338441222733998Search in Google Scholar

Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am 41, 335-350, 2012.10.1016/j.ecl.2012.04.014361401222682634Search in Google Scholar

Yadav RK, Chae SW, Kim HR, Chae HJ. Endoplasmic reticulum stress and cancer. J Cancer Prev 19, 75-88, 2014.10.15430/JCP.2014.19.2.75420416525337575Search in Google Scholar

Zhu S, Xu F, Zhang J, Ruan W, Lai M. Insulin-like growth factor binding protein-related protein 1 and cancer. Clin Chim Acta 431, 23-32, 2014.10.1016/j.cca.2014.01.03724513543Search in Google Scholar

eISSN:
1336-0329
Lingua:
Inglese